Clinical Trial Update: A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase III randomized trial comparing maintenance fluoropyrimidine ± bevacizumab versus fluoropyrimidine alone after induction chemotherapy in metastatic colorec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• fluoropyrimidine (fluoropyrimidine)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: UNKNOWN